ReviewCureus2025
Management of Greater Trochanteric Pain Syndrome: A Narrative Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Anatomy and Pathology of Anterior and Lateral Hip Compartments Bursae: An Ultrasound Structured Approach in Sports Medicine.Diagnostics (Basel, Switzerland) · 2026Review
- 2-Year clinical outcomes following combined iliotibial band and gluteus medius percutaneous ultrasound tenotomy in refractory GTPS.Interventional pain medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Greater trochanteric pain syndrome (GTPS) is characterized by pain and tenderness over the lateral aspect of the hip. It encompasses a spectrum of conditions, including abductor tendinopathy, trochanteric bursitis, and external coxa saltans. Following diagnosis, managing GTPS can be challenging due to the variability in pathology and the wide range of available treatments, many of which are supported by low levels of evidence. At present, there is no clear consensus on the optimal management approach for this condition. This review evaluates the existing literature on GTPS management, aiming to provide clinicians with a framework to guide treatment decisions. Articles were sourced from PubMed and MEDLINE using the terms "greater trochanteric pain syndrome", "trochanteric bursitis", and "gluteal tendinopathy". Findings suggest that targeted physiotherapy (PT) offers superior long-term outcomes compared to shock wave therapy and corticosteroid injections (CSI). In one study, 60.5% of patients reported symptom resolution at 15 months. Extracorporeal shock wave therapy (ESWT) demonstrated a 68.3% improvement in Visual Analogue Scale scores compared to control groups. Combining PT with CSI appears to be more effective in managing acute symptoms than PT alone. The evidence supporting platelet-rich plasma (PRP) remains inconclusive, with ongoing research needed to clarify its role. Surgical intervention is considered when conservative and medical treatments have failed, with various operative techniques showing improvements in pain scores over time. In conclusion, PT and home exercise programs have shown long-term benefits for most patients, although improvements may not be immediate. CSIs can offer short-term relief but are most effective when combined with PT for sustained benefit. Focused ESWT has limited but promising evidence supporting its use, with a low risk of adverse effects. Although PRP has shown potential in some studies, further research is necessary before it can be recommended as part of standard treatment protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.